CTM Clause Samples
The CTM (Critical to Market) clause defines specific requirements, components, or deliverables that are essential for a product or service to be viable in the marketplace. In practice, this clause identifies features or performance standards that must be met before a product can be released, such as compliance with regulatory standards or inclusion of key functionalities. By clearly outlining these critical elements, the CTM clause ensures that both parties understand which aspects of the deliverable are non-negotiable, thereby reducing the risk of disputes and ensuring that the final product meets essential business or regulatory needs.
POPULAR SAMPLE Copied 1 times
CTM commons-logging 1.1 Wrapper around a variety of logging API implementations.
CTM. QS Pharma will manufacture sufficient batches to meet Client requirements. The batches will be manufactured based on the process and composition identified in 4.0. The bulk density of the powder blend will determine the number of batches required to meet the delivery. All CTM batches will be manufactured under cGMP. Prior to the commencement of manufacturing, batch records that specify the manufacturing procedures and acceptance criteria will be prepared by QS Pharma, then supplied for prospective review and approval by Client.
5.1 The Product total batch size is 120,000 tablets (~6 kg of blend and 1.2 kg of API). The quantity specified is intended to cover processing losses and additional tablets for in-process, release testing, stability testing and retention.
5.2 The Placebo total batch size is 100,000 tablets (~5 kg of blend). The quantity specified is intended to cover processing losses and additional tablets for in-process, release testing, stability testing and retention.
5.3 The Product and Placebo batches will be packaged in the Client-specified 90 tablet count in HDPE bottles. Additional tablets will be packaged for release testing, stability testing and retention.
5.4 The CTM storage and material management shall include inventory management, controlled temperature storage at ambient temperature and humidity, domestic and international shipping preparation, overnight and same-day shipping preparation, shipment tracking, receipt confirmation and detailed monthly inventory, receiving and shipping report. The monthly charges are for the remainder of the two packaged batches that is not required for clinical provision at this time and the retention samples of the CTM.
5.5 QS Pharma will label and package the labeled bottles into kits as required by Client study design. The labeling, kit packaging and shipping will require the following activities – batch record generation, 100% label review of Client-provided released labels, labeling Placebo bottles, labeling Product bottles, labeling the box kits, insertion of the Placebo bottles into the appropriate kit boxes, insertion of the Product bottles into the appropriate kit boxes, insertion of the kit boxes into the shipper boxes, labeling the shipper boxes and shipment of the shipper boxes. QA review will also occur prior to, during and after the process.
5.6 The CTM Product release and stability test methods are provided in 3.4. The release testing will cover the time zero analysis for all stability s...
CTM. The Company undertakes to implement, as soon as reasonably practicable and in the best interest of the Company, changes in the compensation structure for senior management of the Company's subsidiary, CTM Media Group, Inc. (“CTM”), that will provide for significant incentive compensation for such members of management, and implement other cost-saving initiatives, in each case as shall be reasonably satisfactory to the Lender.
CTM. THE COMPANY has never suffered a strike, labor problems, interruption of activities, work or other interference which may damage the business of THE COMPANY and likewise, neither THE COMPANY nor THE SELLERS are aware of, or have reasonable causes to know the bases on which said events might occur. THE COMPANY has covered and caused due compliance with all the salaries, premiums, fees and other benefits it is obliged to before the employees and the corresponding authorities.
